Also, it is conceivable that high expression level of ACE2 is an independent risk factor leading to a better prognosis in ovarian cancer patients, and hazard ratio which was demonstrated here indicates ACE2 expression is a protective factor in ovarian cancer. This evidence concerns the gene ACE2 and ovarian cancer.